A diagnosis of cutaneous T-cell lymphoma (CTCL) likely raises many questions and concerns. However, it is important to keep in mind that there are many sources of information and support available to help you cope with this diagnosis. This fact sheet is intended to help you learn about CTCL, find answers to your questions and seek sources of support.

What is CTCL?

CTCL is a rare cancer affecting white blood cells called T-lymphocytes (T-cells). T-cells are important to your immune system, which helps the body fight infection. When T-cells start to grow too quickly, they can accumulate in the body, resulting in a cancer called T-cell lymphoma. T-cell lymphoma primarily affecting the skin is called CTCL. Thanks to recent treatment advances, many patients are able to maintain their quality of life while managing their CTCL, and some are able to remain in remission (cancer stops growing) for long periods of time. The most common forms of CTCL are mycosis fungoides and Sezary syndrome but several other subtypes exist.

Coping with Symptoms of CTCL

T-cells accumulating in the skin cause most patients to develop a rash or scaly patches that may be itchy. In its early stages, CTCL may be mistaken for a skin condition like eczema.

While most patients experience these symptoms without serious complications, it is very important to keep your health care team updated about any changes to your skin. Your doctor can prescribe medications to help you cope with these symptoms.

There are also some things you can do on your own:

Be gentle with your skin. Shower or bathe in lukewarm water. Choose skin cleansers free of fragrances and alcohol. Avoid bubble bath and after-bath powders that may aggravate itching.

Know how to cope with sun exposure. One of the treatments for CTCL is ultraviolet light, so sunlight may have a beneficial effect on CTCL. For example, many patients experience improvements in their rash in the summer. However, it is still advisable to use precautions. Wear a hat with a brim and put on sunscreen for prolonged sun exposure or during the most intense sunlight. If your treatment includes ultraviolet light therapy with psoralen, you will have to wear sunglasses that block the sun’s ultraviolet light. Talk with your health care team about how best to protect your skin from the sun.

Keep a symptom diary. It may take some time to find a skin care plan that works best for you. Keep notes on what you tried, what worked and what did not work.

Treatments for CTCL

The treatment of CTCL depends on several factors, including the extent of skin involved, the type of symptoms and the involvement of nodes or other organs.

Treatment options for CTCL may include:

Skin-directed therapy. Skin-directed therapy for CTCL may include medicated gels or ointments, other medicines you put on your skin, ultraviolet light and radiation. The U.S. Food and Drug Administration approved mechlorethamine gel for the topical treatment of people coping with a type of CTCL called mycosis fungoides who have received prior skin-directed therapy.

Systemic therapy. This treatment involves one or more drugs that are absorbed and delivered across the entire body. The drugs bexarotene and vorinostat are approved to treat CTCL after the cancer has progressed or come back. Romidepsin is approved to treat patients who have received at least one prior chemotherapy drug. Pralatrexate is approved for the treatment of an advanced type of CTCL known as transformed MF (tMF). Recently brentuximab vedotin was approved to treat CTCL that has a certain marker on its surface called CD30. Your doctor will be able to tell you if your CTCL has CD30.

Allogenic stem cell transplantation. Rarely CTCL can become aggressive. In these cases your doctor might recommend an allogeneic stem cell transplantation. For this procedure, stem cells are taken from a donor (usually a brother or sister). Keeping the stem cells on hold, doctors give the patient high doses of chemotherapy to destroy as many cancer cells as possible. The stem cells are then transplanted to the patient to grow into healthy blood cells, forming new blood cells and boosting the person’s defense against infection.

Communicating with Your Health Care Team

Be sure you’re comfortable talking with your health care team. Your health care team may include a dermatologist and cancer specialist as well as your primary care doctor, oncology nurses and oncology social workers. It is important for you to share your concerns and questions with them. Remember, you are a key member of the team.

Be involved in your care. Make a list of questions to ask your doctor or health care team. Taking notes during appointments will help you remember what was discussed.

Understand your treatment plan. Many factors need to be considered in choosing the treatment that’s best for you. Be sure that you understand and are comfortable with the treatment plan your doctor has proposed. Consider getting a second opinion from a specialist in CTCL. Read CancerCare’s fact sheet titled, “When to Get a Second Opinion” for more information.

Share your feelings. When you have CTCL, you may feel uncomfortable because of skin itching or embarrassed by how your skin looks. Consider joining a support group where you can share experiences and learn from other people coping with CTCL. CancerCare’s free support groups, led by professional oncology social workers, connect you with others who are in a similar situation. Organizations such as the Cutaneous Lymphoma Foundation also offer support groups for people coping with CTCL.

Browse by Diagnosis

Browse by Topic

Thumbnail of the PDF version of Coping With Cutaneous T-Cell Lymphoma

Download a PDF(415 KB) of this publication.

Last updated January 11, 2018

The information presented in this publication is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.